Skip to content

Drug interactions

Erlotinib + Erythromycin

Severity: Moderate

Erlotinib and Erythromycin: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Erythromycin may raise erlotinib concentrations and increase adverse effects such as rash, diarrhea, and rarely interstitial lung disease. The effect is expected from CYP3A4 inhibition, as seen with stronger inhibitors.

What this interaction means in plain words

Erlotinib and Erythromycin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Erlotinib belongs to Oncology; Erythromycin belongs to Anti Bacterial.

Evidence level: Moderate

Why it happens

Inhibition of CYP3A4 reduces erlotinib metabolism.

What to do

Monitor for erlotinib toxicity such as severe diarrhea or rash, and consider reducing the erlotinib dose in steps if intolerable reactions occur. Consider a non-inhibiting antibiotic.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Erlotinib and Erythromycin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Erlotinib with Erythromycin?

MediHelp rates the interaction as moderate. Erlotinib and Erythromycin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Erythromycin may raise erlotinib concentrations and increase adverse effects such as rash, diarrhea, and rarely interstitial lung disease. The effect is expected from CYP3A4 inhibition, as seen with stronger inhibitors.

How serious is the interaction between Erlotinib and Erythromycin?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for erlotinib toxicity such as severe diarrhea or rash, and consider reducing the erlotinib dose in steps if intolerable reactions occur. Consider a non-inhibiting antibiotic.

What other medicines interact with Erythromycin?

MediHelp also lists interactions of Erythromycin with, for example, Conivaptan, Dihydroergotamine intranasal, Dihydroergotamine. The full list is on the Erythromycin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in